SCHEMBL4844663

SCHEMBL4844663

COC(=O)Cc1ccc(CN)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
GAA P10253 2/20 0.46
GFER P55789 1/20 0.46
CFD P00746 1/20 0.46
LOXL2 Q9Y4K0 2/20 0.45
CYP4F2 P78329 1/20 0.44
CYP4A11 Q02928 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSP90AB1 P08238 1/20 0.42
KLKB1 P03952 3/20 0.40
PDGFRB P09619 1/20 0.40
FGFR1 P11362 1/20 0.40
PDGFRA P16234 1/20 0.40
FLT1 P17948 1/20 0.40
FGFR3 P22607 1/20 0.40
KDR P35968 1/20 0.40
SLC7A5 Q01650 1/20 0.38
HPGD P15428 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12062913 0.88 ALDH1A1 (0.54) ALDH1A1GAAGFERCYP4F2CYP4A11
SCHEMBL20943235 0.87 ALDH1A1 (0.54) ALDH1A1GAAGFERLOXL2CYP4F2
SCHEMBL10174733 0.85 CYP4F2 (0.45) ALDH1A1GAAGFERCYP4F2CYP4A11
SCHEMBL3924711 0.84 LOXL2 (0.42) ALDH1A1GAAGFERLOXL2CYP4F2
SCHEMBL20943277 0.83 ALDH1A1 (0.45) ALDH1A1GAAGFERCFDLOXL2
SCHEMBL28445862 0.83 CFD (0.45) ALDH1A1GAAGFERCFDLOXL2
SCHEMBL23241569 0.81 RXRA (0.49) GAACFDSMN1; SMN2KLKB1HPGD
SCHEMBL25564405 0.81 KLKB1 (0.40) LOXL2SMN1; SMN2KLKB1KDM4E
SCHEMBL28148703 0.81 CFD (0.44) ALDH1A1GAAGFERCFDLOXL2
SCHEMBL10309764 0.80 ALDH1A1 (0.53) ALDH1A1GAAGFERCYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107522634-B Biaryl urea carboxylic acid derivative or salt thereof, and preparation method and application thereof 复旦大学 2020-09-01 CN disclosed
CN-102746214-A Novel indoline compounds FOURNIER LAB SA 2012-10-24 CN disclosed
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed
CN-101184731-A Indoline compounds FOURNIER LAB SA (FR) 2008-05-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 ALDH1A1 1819/4885GAA 1612/4885GFER 3435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.